We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Label for Diabetes Drug Avandia Outlines Restrictions
New Label for Diabetes Drug Avandia Outlines Restrictions
February 11, 2011
GlaxoSmithKline (GSK) is revising U.S. prescribing information and medication guides for its troubled diabetes medicine Avandia following a September FDA decision to restrict access to the drug.